IndraLab
Statements
reach
"24 In vitro studies confirm its presence in retinal pigment epithelial (RPE)25 cells and retinal endothelial cells.26 Animal studies have shown GLP-1’s benefits in diabetic retinopathy,27 33 oxygen-induced retinopathy,34 and ischemia-reperfusion injury.35 36 Its anti-inflammatory37 39 effects involve suppression of the NOD-like receptor protein 3 (NLRP3) inflammasome.40 41 which is implicated in choroidal neovascularization (CNV) models, where inhibition reduces CNV size.42 44We hypothesized that GLP-1R agonist administration mitigates CNV in AMD by suppressing inflammation."